$0.97
0.01[1.04%]
At close: Apr 24
$0.97
0[0.00%]
After Hours: 7:59PM EDT
Kronos Bio
(NASDAQ:KRON)Kronos Bio Stock (NASDAQ:KRON), Analyst Ratings, Price Targets, Predictions
Kronos Bio Inc has a consensus price target of $8.63, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, HC Wainwright & Co., and HC Wainwright & Co. on December 19, 2023, December 19, 2023, and November 27, 2023. With an average price target of $5.83 between Piper Sandler, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 501.37% upside for Kronos Bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
HC Wainwright & Co.
Goldman Sachs
Berenberg
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Kronos Bio
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/19/2023 | KRON | Buy Now | Kronos Bio | $0.97 | 518.56% | Piper Sandler | Edward Tenthoff | $7 → $6 | Maintains | Overweight | Get Alert |
| 12/19/2023 | KRON | Buy Now | Kronos Bio | $0.97 | 157.73% | HC Wainwright & Co. | Robert Burns | $9 → $2.5 | Maintains | Buy | Get Alert |
| 11/27/2023 | KRON | Buy Now | Kronos Bio | $0.97 | 827.84% | HC Wainwright & Co. | Robert Burns | → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/21/2023 | KRON | Buy Now | Kronos Bio | $0.97 | 827.84% | HC Wainwright & Co. | Robert Burns | $10 → $9 | Maintains | Buy | Get Alert |
| 04/17/2023 | KRON | Buy Now | Kronos Bio | $0.97 | 930.93% | HC Wainwright & Co. | Robert Burns | → $10 | Reiterates | → Buy | Get Alert |
| 11/18/2022 | KRON | Buy Now | Kronos Bio | $0.97 | 930.93% | HC Wainwright & Co. | Robert Burns | $36 → $10 | Maintains | Buy | Get Alert |
| 11/10/2022 | KRON | Buy Now | Kronos Bio | $0.97 | 1343.3% | Goldman Sachs | Salveen Richter | $25 → $14 | Maintains | Buy | Get Alert |
| 11/09/2022 | KRON | Buy Now | Kronos Bio | $0.97 | 621.65% | Piper Sandler | Edward Tenthoff | $13 → $7 | Maintains | Overweight | Get Alert |
| 09/14/2022 | KRON | Buy Now | Kronos Bio | $0.97 | 1137.11% | Berenberg | Zhiqiang Shu | → $12 | Initiates | → Buy | Get Alert |
| 05/24/2022 | KRON | Buy Now | Kronos Bio | $0.97 | 2271.13% | Goldman Sachs | Salveen Richter | $35 → $23 | Maintains | Buy | Get Alert |
| 05/23/2022 | KRON | Buy Now | Kronos Bio | $0.97 | 1240.21% | Piper Sandler | Edward Tenthoff | $30 → $13 | Maintains | Overweight | Get Alert |
| 02/28/2022 | KRON | Buy Now | Kronos Bio | $0.97 | 2992.78% | Piper Sandler | Edward Tenthoff | $50 → $30 | Maintains | Overweight | Get Alert |
| 11/10/2021 | KRON | Buy Now | Kronos Bio | $0.97 | 3611.34% | HC Wainwright & Co. | Robert Burns | — | Maintains | Buy | Get Alert |
| 06/24/2021 | KRON | Buy Now | Kronos Bio | $0.97 | 3508.25% | HC Wainwright & Co. | Robert Burns | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Kronos Bio (KRON)?
The latest price target for Kronos Bio (NASDAQ: KRON) was reported by Piper Sandler on December 19, 2023. The analyst firm set a price target for $6.00 expecting KRON to rise to within 12 months (a possible 518.56% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kronos Bio (KRON)?
The latest analyst rating for Kronos Bio (NASDAQ: KRON) was provided by Piper Sandler, and Kronos Bio maintained their overweight rating.
When was the last upgrade for Kronos Bio (KRON)?
There is no last upgrade for Kronos Bio.
When was the last downgrade for Kronos Bio (KRON)?
There is no last downgrade for Kronos Bio.
When is the next analyst rating going to be posted or updated for Kronos Bio (KRON)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kronos Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kronos Bio was filed on December 19, 2023 so you should expect the next rating to be made available sometime around December 19, 2024.
Is the Analyst Rating Kronos Bio (KRON) correct?
While ratings are subjective and will change, the latest Kronos Bio (KRON) rating was a maintained with a price target of $7.00 to $6.00. The current price Kronos Bio (KRON) is trading at is $0.97, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.